tiprankstipranks
Trending News
More News >
ONO Pharmaceutical Co Ltd (OPHLF)
OTHER OTC:OPHLF
US Market

ONO Pharmaceutical Co (OPHLF) Income Statement

Compare
19 Followers

ONO Pharmaceutical Co Income Statement

Last quarter (Q2 2026), ONO Pharmaceutical Co's total revenue was ¥129.60B, an increase of 5.65% from the same quarter last year. In Q2, ONO Pharmaceutical Co's net income was ¥22.50B. See ONO Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 486.87B¥ 502.67B¥ 447.19B¥ 361.36B¥ 309.28B
Gross Profit
¥ 338.92B¥ 375.55B¥ 337.13B¥ 267.85B¥ 223.71B
Operating Expenses
¥ 279.17B¥ 212.44B¥ 195.16B¥ 152.94B¥ 131.61B
Depreciation and Amortization
¥ 26.89B¥ 18.14B¥ 17.45B¥ 17.72B¥ 15.82B
EBITDA
¥ 91.54B¥ 182.10B¥ 161.90B¥ 122.83B¥ 116.85B
Operating Income
¥ 59.75B¥ 163.10B¥ 141.96B¥ 114.91B¥ 92.10B
Other Income/Expenses
¥ -419.00M¥ 631.00M¥ 1.57B¥ -9.89B¥ 8.79B
Pretax Income
¥ 59.33B¥ 163.73B¥ 143.53B¥ 105.03B¥ 100.89B
Net Income
¥ 50.05B¥ 127.98B¥ 112.72B¥ 80.52B¥ 75.42B
Per Share Metrics
Basic EPS
¥ 106.55¥ 266.57¥ 230.85¥ 162.19¥ 151.11
Diluted EPS
¥ 106.41¥ 266.60¥ 230.79¥ 162.16¥ 151.09
Weighted Average Shares Outstanding
470.32M 480.08M 1.47B 1.49B 1.50B
Weighted Average Shares Outstanding (Diluted)
469.77M 480.04M 1.47B 1.49B 1.50B
Currency in JPY

ONO Pharmaceutical Co Earnings and Revenue History